Business Description
Amcad Biomed Corp
ISIN : TW0004188008
Description
Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. The company's geographical segments include Taiwan, China, and other countries, out of which the majority of the revenue is generated from Europe. The company has two segments: Medical diagnostic software: which is responsible for the development and sales of smart medical imaging diagnostic software device and Precision medical equipment: which is responsible for research, development, manufacturing and sales of high-end ultrasonic probes.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 38.53 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 25.55 | |||||
| Beneish M-Score | -1.83 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.6 | |||||
| 3-Year EBITDA Growth Rate | -3.2 | |||||
| 3-Year EPS without NRI Growth Rate | -8.4 | |||||
| 3-Year FCF Growth Rate | 6 | |||||
| 3-Year Book Growth Rate | -8.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.58 | |||||
| 9-Day RSI | 59.08 | |||||
| 14-Day RSI | 54.1 | |||||
| 6-1 Month Momentum % | -13.88 | |||||
| 12-1 Month Momentum % | -26.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 21.24 | |||||
| Quick Ratio | 20.14 | |||||
| Cash Ratio | 19.49 | |||||
| Days Inventory | 433.79 | |||||
| Days Sales Outstanding | 57.31 | |||||
| Days Payable | 30.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -17.68 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 61.57 | |||||
| Operating Margin % | -111.5 | |||||
| Net Margin % | -93.7 | |||||
| FCF Margin % | -83.58 | |||||
| ROE % | -13.21 | |||||
| ROA % | -10.13 | |||||
| ROIC % | -31.04 | |||||
| ROC (Joel Greenblatt) % | -54.35 | |||||
| ROCE % | -10.82 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 21.51 | |||||
| PB Ratio | 2.43 | |||||
| Price-to-Tangible-Book | 2.75 | |||||
| EV-to-EBIT | -16.7 | |||||
| EV-to-EBITDA | -25 | |||||
| EV-to-Revenue | 16.03 | |||||
| EV-to-FCF | -17.68 | |||||
| Price-to-Net-Current-Asset-Value | 3.58 | |||||
| Price-to-Net-Cash | 4.02 | |||||
| Earnings Yield (Greenblatt) % | -5.98 | |||||
| FCF Yield % | -3.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amcad Biomed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 58.379 | ||
| EPS (TTM) (NT$) | -0.97 | ||
| Beta | 0.45 | ||
| Volatility % | 50.33 | ||
| 14-Day RSI | 54.1 | ||
| 14-Day ATR (NT$) | 0.597918 | ||
| 20-Day SMA (NT$) | 21.5475 | ||
| 12-1 Month Momentum % | -26.32 | ||
| 52-Week Range (NT$) | 20.05 - 36.586758 | ||
| Shares Outstanding (Mil) | 63.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amcad Biomed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amcad Biomed Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Amcad Biomed Corp Frequently Asked Questions
What is Amcad Biomed Corp(ROCO:4188)'s stock price today?
The current price of ROCO:4188 is NT$22.00. The 52 week high of ROCO:4188 is NT$36.59 and 52 week low is NT$20.05.
When is next earnings date of Amcad Biomed Corp(ROCO:4188)?
The next earnings date of Amcad Biomed Corp(ROCO:4188) is .
Does Amcad Biomed Corp(ROCO:4188) pay dividends? If so, how much?
Amcad Biomed Corp(ROCO:4188) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers